4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066817
Chief Scientific Officer gave up 836 shares (to pay taxes)
- Chief Scientific Officer acquired 2,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shanler Stuart · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-12-15 | Exercise or conversion : show line 1 in the form | +1,300 | 263,178 | D | ||
| 2017-12-15 | Shares withheld for taxes : show line 2 in the form | −395 | $24.23 | $9,571 | 262,783 | D |
| 2017-12-18 | Exercise or conversion : show line 3 in the form | +1,450 | 264,233 | D | ||
| 2017-12-18 | Shares withheld for taxes : show line 4 in the form | −441 | $24.12 | $10,637 | 263,792 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-12-15 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −1,300 | 9,100 | D |
| 2017-12-18 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −1,450 | 2,900 | D |
Loading xslF345X03/doc4.xml…